chrisvoncsefalvay/vaers-outcomes huggingface dataset:
administered with the Moderna vaccine which was past beyond the manufacturer's expiration date/manufacturer's expiration date - 24Nov2022, date of administration 26Dec2022; no adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with the Moderna vaccine which was past beyond the manufacturer's expiration date/manufacturer's expiration date - 24Nov2022, date of administration 26Dec2022) and NO ADVERSE EVENT (no adverse event) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Dec-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with the Moderna vaccine which was past beyond the manufacturer's expiration date/manufacturer's expiration date - 24Nov2022, date of administration 26Dec2022) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered with the Moderna vaccine which was past beyond the manufacturer's expiration date/manufacturer's expiration date - 24Nov2022, date of administration 26Dec2022) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (administered with the Moderna vaccine which was past beyond the manufacturer's expiration date/manufacturer's expiration date - 24Nov2022, date of administration 26Dec2022).    Concomitant medications were not reported.                                       No treatment information was provided by the reporter.
Initial report was received from a consumer who is also the patient on 01 December 2010. A male patient (age and past medical history not reported), had received an influenza vaccine (manufacturer, lot number, route and site of administered not reported) on either 22 or 23 September 2010, and an unspecified amount of time later experienced" continuous shoulder muscle spasm (knotted painful muscle) for eight weeks" and "shoulder joint pain and limitation in joint mobility of moderate intensity for eight weeks". No further information was available at the time of the report. The patient reported residual joint pain "now" after ten weeks. Documents held by sender: none.
PASS OUT; This spontaneous report received from a patient from social media via company representative of unspecified age, sex race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry: Unknown) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. (Dose number series was 1). No concomitant medications were reported.  On an unspecified date, the patient experienced pass out. The patient stated that "Your Covid shot made me pass out in the store. I only got yours cause it's only one shot and my job forced it on me" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of pass out was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20211161324-Covid-19 vaccine ad26.cov2.s-Loss of consciousness. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Approximately 10 minutes after MMR vaccine given child had 2 cm area of erythema with minimal swelling around injection site. No shortness of breath or rash.
Redness; toughness; swelling; hot to the touch; radiating pain throughout my arm
Arm significant swelling, heat, and redness after receiving shot Sunday 12-20-09. Pt taking TYLENOL. Swelling is decreasing wit ice, exercise. Pt continuing with ice, ibuprofen, BENADRYL.
Shot given by MA on 8/28/02 on R thigh came to office on  8/29/02 with severe swelling on R thigh. No sign of infection.
Stiffness in arm of vaccine, headache, stiff neck, fevers x 2 days. Area of erythema on right shoulder surrounding vaccine 12 x 8 cm.
Patient received a moderna booster instead of 3rd full dose of moderna.  Patient is immunocompromised
02/19/2020 BOTTOM OF FEET HURT, BODY ACHING, CHILLS/SHIVERING. TEETH CHATTERING. SLEPT WITH HEATING PAD ALL NIGHT. 02/20/2020 BOTTOM FEET CONTINUE TO HURT, BODY ACHING ALL OVER (FEELS LIKE WAS BEAT WITH A BALL BAT), HURTS TO TAKE DEEP BREATH (ACHE NOT DIFFICULTY BREATHING), BACK HURTS THE WORST.  400MG. IBUPROFEN TAKEN. TOLD TO CALL PCP. PCP STATES BODY'S NORMAL REACTION TO VACCINE, TAKE IBUPROFEN FOR THE ACHES AND PAINS   TOOK ANOTHER IBUPROFEN AND ALL SYMPTOMS GONE BY 10:30 a.m.
Post vaccination, patient began to feel  faint, diaphoretic, cyanotic lips, and nauseated with several episodes of vomiting.  She was hypotensive (BP machine was unable to capture BP several times)  Symptoms later subsided and BP was 130/74.  She was A0x4.
Fever, severe aches in joints, welts on arm. Patient had doctor visit. Treatment was time. MD stated this was a typical reaction.
suspected myocarditis - 1 episode of 30 minutes of chest pain, followed by palpitations. PVCs on monitor and 1 recorded run of 7 beats of NSVT
Vomiting, nauseous and a migraine headache lasted for 24 hours then symptoms stop.
Shingles severe pain  24/7 for more than 2 years.  On my back, up my left side and over my left stomach.  No end in sight.
Always been having sinus problem and since got the covid-19 shot it has stop sinus problem since the vaccine had no sinus at all; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 02Apr2021 at 12:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included sinus. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 12:00, the patient always been having sinus problem and since he got the COVID-19 shot it has stopped his sinus problem since the vaccine, he had no sinus at all. The clinical outcome of the event always been having sinus problem and since he got the covid-19 shot it has stopped his sinus problem since the vaccine, he had no sinus at all was unknown. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 24Apr2021 at 12:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report as received from a nurse from a physician's office via a company representative refers to a male patient of unknown age. The patient's pertinent medical history, drug reaction/allergies or concomitant information were not reported.    On an unknown date, the patient was vaccinated with ZOSTAVAX, subcutaneouslly (dosage schedule, lot # and expiration date were not reported) for prevention of shingles (prophylaxis). On an unknown date, after receiving vaccination with ZOSTAVAX, the patient "broke out from head to toe in a rash" (rash generalised).  The outcome of rash generalised was reported as recovered.  The reporter did not assess causality between the rash generalised and the vaccination with ZOSTAVAX. There was no product quality (PQC) involved. Additional information has been requested.
This spontaneous report as received from the patient's mother, refers to her male son of unknown age. Medical history and concurrent conditions were not reported. On an unknown date the patient, was vaccinated with a dose of GARDASIL (administration route, lot number and expiration date were not reported). No concomitant medications were reported. The patient's mother stated that he son possibly got "sick" after the vaccine was administered, but did not provide any additional information. The outcome of the unspecified sickness was unknown. Additional information is not expected, because there is no contact information to follow up.
She got her vaccine (booster), she felt like she was coming down with a mild case of the flu.  She had long-haul symptoms from having COVID  before.  She felt feverish, mild sore throat, nausea.  These symptoms lasted for about 2 days, and then it cleared and has been OK since other than the residual from having COVID.    She had COVID in 2019 and has had residual symptoms from it.  It was to the point that she could not walk and has had vertigo issues since then.  She went to her PCP who told her that she did not have COVID.  She then had to go to an ENT who told her that it was from long-term COVID.   She did not have any problems with vertigo prior to having COVID.    She just wants people to know if they get COVID virus and you can have extreme symptoms and that tinnitus has been severe and it has gradually gotten worse.
11y10m female given 12+ bivalent pfizer gray cap rather than 5-11 bivalent pfizer orange cap. pt had fever and malaise post vaccination but still able to participate in activities. aware of error. PCP Dr aware.
This spontaneous report as received from a other healthcare worker refers to a patient of unknown age and gender who on 02-NOV-2012, was vaccinated with a dose of VARIVAX (Merck) (dose and lot number not reported) instead of ZOSTAVAX (Merck) due to human error. No other co-suspects were reported. No concomitant medications were reported. No treatment information was reported. No adverse effect reported. At the time of the report, the patient outcome for adverse events was unknown. Additional information has been requested.
Resident noted to have a pink rash - Dime sized areas on bilateral upper extremities, rash improving
Case previously recorded as MA2009-3835. Initial case report received from a pharmacist via MedCom on 06 NOV 2009. Four patients with 3-year-old were each vaccinated with 0.5mL S-OIV FLUVIRIN (batch no. 102041P1) i.m. on 05 NOV 2009. No adverse event was reported. MedCom reference no.: NA09-007694.
Patient presented to BIDMC on 02/23/21 with ~5d of sore throat and intractable fever and was found to have fulminant myocarditis.  She required ICU stay with VA ECMO and Impella circulatory support from 02/25/21-03/03/21.  She received a course of hydrocortisone. Cause of myocarditis was unclear but felt to be viral or post-viral versus inflammatory.  As of this submission she has been transferred to the cardiac floor and seems to be recovering.  Symptoms started ~14d after 1st dose COVID vaccine.  She also had self limited COVID infection in early January, 2021.
Acute hypoxic respiratory failure secondary to Covid pneumonia; Continue Decadron -total 10 days, completed 5 days of remdesivir, cxray showed -Patchy basilar reticular lung opacities consistent with atypical infection.Empiric antibiotic with IV Rocephin and Zithromax Antitussives /mucolytic's for cough BD,Supplemental oxygen-she has qualified for home oxygen, Supportive care including incentive spirometry prone positioning as tolerated
Moderna COVID-19 Vaccine EUA Increased heart rate and lightheadedness lasting 3-5 minutes. No treatment or lasting effects.
high fever; lethargic; did not receive 4th dose of Prevnar vaccine; This is a spontaneous report from a contactable nurse. An infant male patient received pneumococcal 13-val conjugate vaccine (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) (at age 6-month-old) as dose number 3, single for immunization. The patient's medical history and concomitant medications were not reported. After third dose of Prevnar vaccine, patient ran a high fever of 105F and was lethargic for 5 days and ultimately did not receive 4th dose of Prevnar vaccine. He has had no other issue with vaccines. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever 101.3 lasting full day (treated with Motrin after vomiting) Projectile Vomiting 3 separate times - 5:15am, 7:30am, 9:15am (Fluoxetine was skipped this morning due to vomiting) Chills
vaccionation adverse reaction; vaccination complication; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION COMPLICATION (vaccionation adverse reaction) and VACCINATION COMPLICATION (vaccination complication) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Non-Hodgkin's lymphoma. Concomitant products included IBRUTINIB (IMBRUVICA) from 23-Dec-2020 to an unknown date.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (vaccionation adverse reaction) and VACCINATION COMPLICATION (vaccination complication). At the time of the report, VACCINATION COMPLICATION (vaccionation adverse reaction) and VACCINATION COMPLICATION (vaccination complication) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
None. Patient was given wrong dose of flu on 11/2/10. Lot: UT3574BA.
Patient received vaccine and had a short episode of being diaphoretic and passed out. Patient regained consciousness. patient admitted she did not have breakfast prior to coming to clinic and took morning medications at 0800. Patient was alert and oriented, MD stat called and was assessed by MD at clinic. Additional observation for 30 minutes was recommended with RN. Vital signs stable upon check- bp:103/57 hr:66 O2:99% on Room air Temp: 96.4 F Respiratory rate: 16
The patient became extremely fatigued, ran a fever, and the hair on his head began falling out in large quantities.  The fever went away after a couple of days, but the fatigue and hair loss continued.  The patient received the second Moderna dose on 6/16/21 (050C21A).  Patient started sleeping over 12 hours a day and the hair loss (alopecia) continued.  There was tons of hair on his pillow, sink and shower floor.  The hair on his head is still thin all over, but has quit falling out in abnormal quantities (as of 10/2/2021), and has not started to regrow yet.  The patient is back to his normal sleeping habits and feels better.
This spontaneous case, initially received on 09-Jan-2017, was reported by a health professional and concerns a(n) 54-year-old female patient. Weight: not provided; Height: not provided. Concomitant medication: refer to appropriate report section. Administration of company suspect drug(s): On an unknown date, the patient received AFLURIA. Dose regimen: 0.5 ml, Route of administration. Batch number: 13749221A. No additional suspect drugs. On an unspecified date, the patient was administered AFLURIA from a multi dose vial that was punctured over 28 days. No adverse effects were noted. Special circumstances: Drug administration error without adverse event.
This study case was received from the investigator on 27 August 2012. A male subject (date of birth not reported) with no reported past medical history had received a ACAM2000 (lot number, route, site and date of administration not reported) and an unspecified amount of time later was found to have on 15 July 2009 an elevated Troponin, central laboratory level of 0.15 ng/ml (also with a reported date of 20 July 2009). The subject had a rapid Troponin I level on 15 July 2009 that was within normal limits (negative). A repeat Troponin on 20 July 2009 was < 0.10 ng/mL and an ECG on the same date was normal "Repeat test normal". The subject had no concomitant medications. No treatments were reported. No other reported visits, no chest x-ray, no echo and no labs. The subject had no concomitant medications. No further information was available at the time of the report. The subject's outcome was recovered on 20 July 2009. According to the investigator, the event of elevated Troponin was considered an other important event and possibly related to vaccination. Per the Investigator, this represents a case of potential myopericarditis and was referred to the study's adjudication committee for assessment. Documents held by sender: none.
1 month after my daughter 2nd HPV vaccine she began having symptoms she has never had before. Symptoms are sore throat, nose hurting, headache, extreme fatigue, then body aches, eyes hurting, dizziness, coughing, hot and cold, nausea, stomach pain, abdominal cramps, bad dreams, hurts to close her eyes, body shakes, fever, spinning, blurry vision, visual disturbances, insomnia, depression, loss of interest.
The whole side of my face went numb and tingling; In my mouth it looked like lichen planus; Felt weird and funny; I had big old splotches under my arm, across my back, and where I had the vaccine.; whole side of my face went tingling; When there was weird sensations going down my arm, it was getting numb; I had a rash that was splotchy and looked like snake skin from my elbow down to my wrist; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (The whole side of my face went numb and tingling), ORAL LICHEN PLANUS (In my mouth it looked like lichen planus), FEELING ABNORMAL (Felt weird and funny), SKIN DISCOLOURATION (I had big old splotches under my arm, across my back, and where I had the vaccine.) and PARAESTHESIA (whole side of my face went tingling) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Raynaud's syndrome, Autoimmune disorder (Autoimmune disorder by groin area and seven other autoimmune issues), Psoriasis and Alopecia.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (The whole side of my face went numb and tingling), ORAL LICHEN PLANUS (In my mouth it looked like lichen planus), FEELING ABNORMAL (Felt weird and funny), SKIN DISCOLOURATION (I had big old splotches under my arm, across my back, and where I had the vaccine.), PARAESTHESIA (whole side of my face went tingling), SENSORY DISTURBANCE (When there was weird sensations going down my arm, it was getting numb) and RASH (I had a rash that was splotchy and looked like snake skin from my elbow down to my wrist). The patient was treated with DEXAMETHASONE ongoing since an unknown date at a dose of UNK dosage form, qd and NYSTATIN ongoing since an unknown date at a dose of UNK dosage form, qd. At the time of the report, HYPOAESTHESIA (The whole side of my face went numb and tingling), ORAL LICHEN PLANUS (In my mouth it looked like lichen planus), FEELING ABNORMAL (Felt weird and funny), SKIN DISCOLOURATION (I had big old splotches under my arm, across my back, and where I had the vaccine.), PARAESTHESIA (whole side of my face went tingling), SENSORY DISTURBANCE (When there was weird sensations going down my arm, it was getting numb) and RASH (I had a rash that was splotchy and looked like snake skin from my elbow down to my wrist) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   This case was linked to MOD-2021-212507 (Patient Link).
No pain or adverse event for the first 4 hours after vaccination. Starting at 2pm, which was 4 hours after my vaccine, , my chest began to tighten. It was not severe; I took a normal walk and was just mildly uncomfortable. It escalated hourly for about 10- 12 hours. At 8pm, the pain, pressure, and tightness around the chest went from mild to moderate, from a pain level of 2 to about 3 or 4. The sensation was one of a stack of books on my chest. There was pressure and mild pain (again, not severe), about 8-10 inches horizontally across my chest, from about the bottom of my sternum to the collarbone. I also felt some pressure in my lower throat, perhaps the bottom third of my neck. I did not have any shortness or breath, swelling, or difficulty swallowing. At about 9 pm, I became itchy on my neck, ankles, and flank. I developed some red spots, which were not large enough to be hives, They mostly became red from my itching, though they were more moderately itchy than seriously itchy. I have had hives before, and they did not appear to be hives, more just isolated red spots. Once I became itchy, I went to the ER. They worked me up for cardiac issues and a blot clot, but all tests were negative. I did not take any medication other than my standard Oxcarbazepine 8pm dose of 300 mg. The itchiness went away at about 11pm (two hours after onset), and the chest pain did not worsen. The following morning, it was significantly better, and about 36 hours after I first received the vaccine, it was gone entirely.
Patient reports chills and shaking, temp max of 101.8, body aches, fatigue, nausea, headache and dizzy spells after her vaccine. She states that they lasted for 24 hours and have resolved.  Patient received the BioNTech Pfizer Covid 19 vaccine